Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Innovex International, Inc.DRQ · Entity 4462 | Director · CEO | December 31, 2021 | January 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Innovex International, Inc.
Report date December 31, 2021 · Filed January 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 275,078 |
Reported balance
After 2021-12-31 transaction · row 1
1 source rowRow 1 · 2021-12-31 · Sale · Disposed 57,282 · Balance 275,078 F1: Sales to cover tax obligations of vested restricted stock and performance units awards pursuant to a Rule 10b5-1 plan adopted on December 1, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Sales to cover tax obligations of vested restricted stock and performance units awards pursuant to a Rule 10b5-1 plan adopted on December 1, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2021 Filed Jan 3, 2022 13:37 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 57,282 | $19.46 | $1,114,707.72 |
DisclosureSEC source: 0001209191-22-000020 · doc4.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,078 F1 · kind: Sales to cover tax obligations of vested restricted stock and performance units awards pursuant to a Rule 10b5-1 plan adopted on December 1, 2021. Read SEC document |
| October 29, 2021 Filed Nov 1, 2021 13:35 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 202 | $23.42 | $4,730.84 |
DisclosureSEC source: 0001209191-21-062157 · doc4.xml · nonDerivative · entry 3 DeBerry Blake T. · CIK 0001522928 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,246 F2 · kind: Sales pursuant to a Rule 10b5-1 plan adopted on May 19, 2021. F4 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.38 to $23.46 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 29, 2021 Filed Nov 1, 2021 13:35 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 28,603 | $22.82 | $652,720.46 |
DisclosureSEC source: 0001209191-21-062157 · doc4.xml · nonDerivative · entry 2 DeBerry Blake T. · CIK 0001522928 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,448 F2 · kind: Sales pursuant to a Rule 10b5-1 plan adopted on May 19, 2021. F3 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.28 to $23.37 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 28, 2021 Filed Nov 1, 2021 13:35 UTC | Innovex International, Inc. DRQ · Entity 4462 | GrantCommon Stock | 30,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-062157 · doc4.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,051 F1 · shares: These shares vested pursuant to the terms of performance unit awards granted on October 28, 2018. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 18:26 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 1,656 | $26.37 | $43,668.72 |
DisclosureSEC source: 0001209191-21-058825 · doc4.xml · nonDerivative · entry 2 DeBerry Blake T. · CIK 0001522928 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,882 F1 · kind: Sales pursuant to a Rule 10b5-1 plan adopted on May 19, 2021. F3 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.17 to $26.58 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 18:26 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 3,344 | $25.81 | $86,308.64 |
DisclosureSEC source: 0001209191-21-058825 · doc4.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,538 F1 · kind: Sales pursuant to a Rule 10b5-1 plan adopted on May 19, 2021. F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.15 to $26.14 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 13:43 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 5,000 | $34.56 | $172,800.00 |
DisclosureSEC source: 0001209191-21-044685 · doc4.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,882 F1 · kind: Sales pursuant to a Rule 10b5-1 plan adopted on May 19, 2021. F2 · kind: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.31 to $35.09 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.31 to $35.09 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 13:16 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 10,000 | $32.96 | $329,600.00 |
DisclosureSEC source: 0001209191-21-024341 · doc4.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,882 F1 · kind: Sales pursuant to a Rule 10b5-1 plan adopted on June 23, 2020. F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.43 to $33.41 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 29, 2020 Filed Oct 30, 2020 16:02 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 36,245 | $23.60 | $855,382.00 |
DisclosureSEC source: 0001209191-20-056290 · doc4.xml · nonDerivative · entry 3 DeBerry Blake T. · CIK 0001522928 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,882 F2 · kind: Sales to cover tax obligations of vested restricted stock and performance units awards pursuant to a Rule 10b5-1 plan adopted on June 23, 2020. F3 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.16 to $24 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 28, 2020 Filed Oct 30, 2020 16:02 UTC | Innovex International, Inc. DRQ · Entity 4462 | GrantCommon Stock | 57,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056290 · doc4.xml · nonDerivative · entry 2 DeBerry Blake T. · CIK 0001522928 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,127 F1 · shares: These shares vested pursuant to the terms of performance unit awards granted on October 28, 2017. Read SEC document |
| October 28, 2020 Filed Oct 30, 2020 16:02 UTC | Innovex International, Inc. DRQ · Entity 4462 | GrantCommon Stock | 58,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056290 · doc4.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,699 Read SEC document |
| October 01, 2020 Filed Oct 2, 2020 17:10 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 10,000 | $24.03 | $240,300.00 |
DisclosureSEC source: 0001209191-20-052955 · doc4.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,024 F1 · kind: Sales pursuant to a Rule 10b5-1 plan adopted on June 23, 2020. F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.62 to $24.48 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 17:52 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 4,233 | $44.70 | $189,215.10 |
DisclosureSEC source: 0000899243-19-026936 · doc4.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,024 F1 · kind: Sales to cover tax obligations of vested restricted stock and performance unit awards. Read SEC document |
| October 29, 2019 Filed Oct 30, 2019 19:49 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 10,769 | $43.92 | $472,974.48 |
DisclosureSEC source: 0000899243-19-026329 · doc4.xml · nonDerivative · entry 4 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,257 F2 · kind: Sales to cover tax obligations of vested restricted stock and performance unit awards pursuant to a Rule 10b5-1 plan adopted on August 21, 2019. F4 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.80 to $44.125 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 29, 2019 Filed Oct 30, 2019 19:49 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 18,317 | $43.40 | $794,957.80 |
DisclosureSEC source: 0000899243-19-026329 · doc4.xml · nonDerivative · entry 3 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,026 F2 · kind: Sales to cover tax obligations of vested restricted stock and performance unit awards pursuant to a Rule 10b5-1 plan adopted on August 21, 2019. F3 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.80 to $43.79 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 19:49 UTC | Innovex International, Inc. DRQ · Entity 4462 | GrantCommon Stock | 53,662 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-026329 · doc4.xml · nonDerivative · entry 2 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,343 F1 · shares: These shares vested pursuant to the terms of performance unit awards granted on October 28, 2016. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 19:49 UTC | Innovex International, Inc. DRQ · Entity 4462 | GrantCommon Stock | 31,439 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-026329 · doc4.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,681 Read SEC document |
| July 30, 2019 Filed Jul 31, 2019 20:12 UTC | Innovex International, Inc. DRQ · Entity 4462 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $48.77 | $0.00 |
DisclosureSEC source: 0001562180-19-004108 · primarydocument.xml · derivative · entry 3 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2019-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options became exercisable in equal increments on the first, second, third and fourth anniversaries of the grant. The grant date was October 28, 2009. Read SEC document |
| July 30, 2019 Filed Jul 31, 2019 20:12 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 10,000 | $51.63 | $516,300.00 |
DisclosureSEC source: 0001562180-19-004108 · primarydocument.xml · nonDerivative · entry 2 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,242 F1 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.60 to $51.705 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| July 30, 2019 Filed Jul 31, 2019 20:12 UTC | Innovex International, Inc. DRQ · Entity 4462 | Exercise / conversionCommon Stock | 10,000 | $48.77 | $487,700.00 |
DisclosureSEC source: 0001562180-19-004108 · primarydocument.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:04 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 2,000 | $45.82 | $91,640.00 |
DisclosureSEC source: 0001562180-19-002122 · primarydocument.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,242 F1 · kind: Sales pursuant to a Rule 10b5-1 plan adopted on June 12, 2017. F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.80 to $45.85 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 29, 2018 Filed Oct 30, 2018 18:04 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 7,887 | $41.86 | $330,149.82 |
DisclosureSEC source: 0001562180-18-004321 · primarydocument.xml · nonDerivative · entry 4 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,242 F2 · kind: Sales to cover tax obligations of vested restricted stock and performance unit awards pursuant to a Rule 10b5-1 plan adopted on June 12, 2017. F4 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.71 to $42.12 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 29, 2018 Filed Oct 30, 2018 18:04 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 8,083 | $41.22 | $333,181.26 |
DisclosureSEC source: 0001562180-18-004321 · primarydocument.xml · nonDerivative · entry 3 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,129 F2 · kind: Sales to cover tax obligations of vested restricted stock and performance unit awards pursuant to a Rule 10b5-1 plan adopted on June 12, 2017. F3 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.71 to $41.705 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 28, 2018 Filed Oct 30, 2018 18:04 UTC | Innovex International, Inc. DRQ · Entity 4462 | GrantCommon Stock | 14,835 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-18-004321 · primarydocument.xml · nonDerivative · entry 2 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,212 F1 · shares: These shares vested pursuant to the terms of performance unit awards granted on October 28, 2015. Read SEC document |
| October 28, 2018 Filed Oct 30, 2018 18:04 UTC | Innovex International, Inc. DRQ · Entity 4462 | GrantCommon Stock | 30,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-18-004321 · primarydocument.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,377 Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 23:29 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 2,000 | $52.35 | $104,700.00 |
DisclosureSEC source: 0001562180-18-004132 · primarydocument.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,208 F1 · kind: Sales pursuant to a Rule 10b5-1 plan adopted on June 12, 2017. Read SEC document |
| April 02, 2018 Filed Apr 2, 2018 23:32 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 170 | $44.38 | $7,544.60 |
DisclosureSEC source: 0001562180-18-001782 · primarydocument.xml · nonDerivative · entry 2 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,208 F1 · kind: Sales pursuant to a Rule 10b5-1 plan adopted on June 12, 2017. F3 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.30 to $44.45 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 02, 2018 Filed Apr 2, 2018 23:32 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 1,830 | $43.95 | $80,428.50 |
DisclosureSEC source: 0001562180-18-001782 · primarydocument.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,378 F1 · kind: Sales pursuant to a Rule 10b5-1 plan adopted on June 12, 2017. F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.30 to $44.25 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 17:09 UTC | Innovex International, Inc. DRQ · Entity 4462 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $20.98 | $0.00 |
DisclosureSEC source: 0001562180-17-003608 · primarydocument.xml · derivative · entry 3 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2018-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options became exercisable in equal increments on the first, second, third and fourth anniversaries of the grant. The grant date was October 28, 2008. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 17:09 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 10,000 | $44.66 | $446,600.00 |
DisclosureSEC source: 0001562180-17-003608 · primarydocument.xml · nonDerivative · entry 2 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,208 F1 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.50 to $44.775 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 17:09 UTC | Innovex International, Inc. DRQ · Entity 4462 | Exercise / conversionCommon Stock | 10,000 | $20.98 | $209,800.00 |
DisclosureSEC source: 0001562180-17-003608 · primarydocument.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2017 Filed Oct 31, 2017 18:33 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 14,819 | $41.49 | $614,840.31 |
DisclosureSEC source: 0001562180-17-003404 · primarydocument.xml · nonDerivative · entry 3 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,208 F2 · kind: Sales to cover tax obligations of vested restricted stock and performance unit awards pursuant to a Rule 10b5-1 plan adopted on June 12, 2017. F3 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.225 to $41.675 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 28, 2017 Filed Oct 31, 2017 18:33 UTC | Innovex International, Inc. DRQ · Entity 4462 | GrantCommon Stock | 17,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-003404 · primarydocument.xml · nonDerivative · entry 2 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,027 F1 · shares: These shares vested pursuant to the terms of performance unit awards granted on October 28, 2014. Read SEC document |
| October 28, 2017 Filed Oct 31, 2017 18:33 UTC | Innovex International, Inc. DRQ · Entity 4462 | GrantCommon Stock | 31,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-17-003404 · primarydocument.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,175 Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 14:20 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 2,000 | $43.49 | $86,980.00 |
DisclosureSEC source: 0001562180-17-003129 · primarydocument.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,850 F1 · kind: Sales pursuant to a Rule 10b5-1 plan adopted on June 12, 2017. F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.45 to $43.75 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 21:31 UTC | Innovex International, Inc. DRQ · Entity 4462 | Exercise / conversionStock Option · Derivative | 10,000 | $0.00 Strike: $54.13 | $0.00 |
DisclosureSEC source: 0001562180-16-003807 · primarydocument.xml · derivative · entry 3 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options became exercisable in increments on the first, second, third and fourth anniversaries of the grant. The grant date was October 26, 2007. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 21:31 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 10,000 | $64.10 | $641,000.00 |
DisclosureSEC source: 0001562180-16-003807 · primarydocument.xml · nonDerivative · entry 2 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,850 F1 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.10 to $64.15 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 13, 2016 Filed Dec 15, 2016 21:31 UTC | Innovex International, Inc. DRQ · Entity 4462 | Exercise / conversionCommon Stock | 10,000 | $54.13 | $541,300.00 |
DisclosureSEC source: 0001562180-16-003807 · primarydocument.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 21:51 UTC | Innovex International, Inc. DRQ · Entity 4462 | SaleCommon Stock | 9,101 | $47.59 | $433,116.59 |
DisclosureSEC source: 0001562180-16-003334 · primarydocument.xml · nonDerivative · entry 3 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,850 F3 · kind: Sale to cover tax obligations of vested restricted stock and performance unit awards pursuant to a 10b5-1 plan adopted on May 16, 2013. F4 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.45 to $47.8583 inclusive. The reporting person has provided to the issuer and will provide any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| October 28, 2016 Filed Nov 1, 2016 21:51 UTC | Innovex International, Inc. DRQ · Entity 4462 | GrantCommon Stock | 8,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-16-003334 · primarydocument.xml · nonDerivative · entry 2 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,951 F2 · shares: These shares vested pursuant to the terms of performance unit awards granted on October 28, 2013. Read SEC document |
| October 28, 2016 Filed Nov 1, 2016 21:51 UTC | Innovex International, Inc. DRQ · Entity 4462 | GrantCommon Stock | 26,831 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-16-003334 · primarydocument.xml · nonDerivative · entry 1 DeBerry Blake T. · CIK 0001522928 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,141 F1 · balance_after: Excludes 53 shares not accurately deducted in Form 4 dated October 30, 2015 due to administrative error. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.